Company Announcements

Covered Bond Programme Supplement Annual Report

Source: RNS
RNS Number : 3074I
Commonwealth Bank of Australia
07 August 2019
 

 

Publication of Supplementary Prospectus

The following supplementary prospectus (the Supplementary Prospectus) has been approved by the UK Listing Authority and is available for viewing:

Commonwealth Bank of Australia

U.S.$30,000,000,000 CBA Covered Bond Programme unconditionally and irrevocably guaranteed as to payments of interest and principal by

 

Perpetual Corporate Trust Limited (incorporated with limited liability in the Commonwealth of Australia and having Australian Business Number 99 000 341 533) as trustee of the CBA Covered Bond Trust

 

Supplementary Prospectus dated 7 August 2019 to the Prospectus dated 3 December 2018 as supplemented on 6 February 2019, 21 March 2019, 8 April 2019, 22 May 2019 (as so supplemented, the "Prospectus").

To view the full document, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/3074I_1-2019-8-7.pdf

 

For further information, please contact:

Commonwealth Bank of Australia
1 New Ludgate, 60 Ludgate Hill, London, EC4M 7AW

Telephone : 0207 710 3999

DISCLAIMER ‑ INTENDED ADDRESSEES

Please note that the information contained in the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Programme Circular) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Supplementary Prospectus is not addressed.  Prior to relying on the information contained in the Supplementary Prospectus you must ascertain from the Programme Circular whether or not you are part of the intended addressees of the information contained in the Supplementary Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PSPFMGGRKNLGLZM